Similar articles

• Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.

  U.S. Preventive Services Task Force. U.S. Preventive Services Task Force. Ann Intern Med. 2005 May 17;142(10):855-60. Ann Intern Med. 2005. PMID: 15897536
• Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.

  U.S. Preventive Services Task Force. U.S. Preventive Services Task Force. Ann Intern Med. 2002 Nov 19;137(10):I48. Ann Intern Med. 2002. PMID: 12435233 No abstract available.
• Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.

  Dick SE, DeWitt DE, Anawalt BD. Dick SE, et al. Am J Manag Care. 2002 Jan;8(1):95-104; quiz 105-6. Am J Manag Care. 2002. PMID: 11814176 Review.
• Summaries for patients. Hormone therapy to prevent chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.

  [No authors listed] [No authors listed] Ann Intern Med. 2005 May 17;142(10):I59. doi: 10.7326/0003-4819-142-10-200505170-00004. Ann Intern Med. 2005. PMID: 15897529 No abstract available.
• Justification for the use of HRT in the long-term prevention of osteoporosis.

  Stevenson JC. Stevenson JC. Maturitas. 2005 Jun 16;51(2):113-26. doi: 10.1016/j.maturitas.2005.01.012. Maturitas. 2005. PMID: 15917151 Review.